U.S. Congress - S.2295 Patient Safety and Generic Labeling Improvement Act
S.2295 - Patient Safety and Generic Labeling Improvement Act
A bill to permit manufacturers of generic drugs to provide additional warnings with respect to such drugs in the same manner that the Food and Drug Administration allows brand names to do so. view all titles (2)
All Bill Titles
- Official: A bill to permit manufacturers of generic drugs to provide additional warnings with respect to such drugs in the same manner that the Food and Drug Administration allows brand names to do so. as introduced.
- Short: Patient Safety and Generic Labeling Improvement Act as introduced.
This Bill currently has no wiki content. If you would like to create a wiki entry for this bill, please Login, and then select the wiki tab to create it.
| Latest Actions View All Actions [3] | |
|---|---|
| Apr 18th | |
| Apr 18th | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
| Apr 18th | Sponsor introductory remarks on measure. (CR S2497-2498, S2499-2500) |
Vote on This Bill
-
Share This Bill
More Share via Email
